No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CKPT240816C2500
- 0.30
- -0.07-18.92%
15min DelayClose Jul 22 15:52 ET
0.35High0.10Low
0.35Open0.37Pre Close152 Volume336 Open Interest2.50Strike Price2.62KTurnover97.30%IV12.45%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type0.5496Delta0.6287Gamma9.96Leverage Ratio-0.0053Theta0.0008Rho5.47Eff Leverage0.0026Vega
Intraday
- 5D
- Daily
News
Checkpoint Therapeutics Price Target Maintained With a $34.00/Share by HC Wainwright & Co.
Analysts' Top Healthcare Picks: Checkpoint Therapeutics (CKPT), Mediwound (MDWD)
Checkpoint Therapeutics, GC Cell Collaborate on Cancer Research; Shares Rise
Checkpoint, GC Cell to Evaluate Combo Cancer Therapy
Express News | GC Cell And Checkpoint Therapeutics To Explore Combined Therapeutic Potential Of Cosibelimab
Checkpoint Therapeutics (CKPT.US) has submitted its application for the marketing of PD-L1 targeted antibodies to the US FDA.
According to the SmartFinance APP, Checkpoint Therapeutics (CKPT.US) recently announced that it has resubmitted its biological product license application (BLA) for the PD-L1 targeted antibody Cosibelimab to the United States FDA for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) patients who are not suitable for radical surgery or radiotherapy. Data shows that Cosibelimab is a potential differentiated, high-affinity, fully human IgG1 subtype monoclonal antibody that directly binds with PD-L1 to block P.
Comments
$Checkpoint Therapeutics(CKPT.US$ get the feeling this is gonna pop...
March 16th, the next FDA review... zzz I turn to be very interested following these FDA news
$OptiNose(OPTN.US$
when are the next date for $Checkpoint Therapeutics(CKPT.US$ , $Fortress Biotech(FBIO.US$ , and $Brainstorm Cell Therapeutics(BCLI.US$ ?
all of these stocks currently not good fundamentally... some even minus PBV
$OptiNose(OPTN.US$
when are the next date for $Checkpoint Therapeutics(CKPT.US$ , $Fortress Biotech(FBIO.US$ , and $Brainstorm Cell Therapeutics(BCLI.US$ ?
all of these stocks currently not good fundamentally... some even minus PBV
$SPDR S&P Biotech ETF(XBI.US$
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
14
1
no news, guys I also reenter after some gains. $Fortress Biotech(FBIO.US$ . but this one actually has a lot of project, sadly it lack of cash and equity. it seems so they issue warrant monthly. DER still high. potential BEP, but a bit worried if per month issued warrant. it has position as stock holder in $Mustang Bio(MBIO.US$, $Journey Medical(DERM.US$ , $Checkpoint Therapeutics(CKPT.US$ .
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US$ by ...
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US$ by ...
2
$Checkpoint Therapeutics(CKPT.US$ Yes CKPT got a CRL 12/18/23 for the place drug is manufactured. And partner with $Fortress Biotech(FBIO.US$ . My post came from FDA calendar as late as 1/2/24? They both have several drugs in pipeline! i try as hard as i can to post only factual information! I see no info that FBIO got any recent response from FDA? And thats why i posted. That and i seen still on calendar! So now i cant find positive information and need to delete...
2
23
Read more